Diagnostic Imaging Pathways Logo

  • Pathways
  • Normal Anatomy
  • Medical Images
  • Radiation Module
  • Radiation Quiz
  • Menu
  • Search

Foot ulcer (diabetic)

Population Covered By The Guidance

This pathway provides guidance on the imaging of diabetic patients with diabetic foot ulcers

Lead Researcher: Charlotte Humphries

Experts & Contributors: Ashley Bennett (images), Eamon Koh, Michael Mason

Editorial Panel: Core membership
Link to Editorial Panel

Date reviewed: August 2013

Date Published: August 2013

Image 1a and 1b (Plain Radiography): DP and lateral views of a foot showing cortical erosion of the 4th metatarsal head in keeping with osteomyelitis (arrow). There is a small gas locule in the soft tissue between the 4th and 5th metatarsal heads which could indicate a gas forming organism causing an abscess (arrowhead).

Diabetic Foot Osteomyelitis

Image 1a and 1b (Plain Radiography): DP and lateral views of a foot showing cortical erosion of the 4th metatarsal head in keeping with osteomyelitis (arrow). There is a small gas locule in the soft tissue between the 4th and 5th metatarsal heads which could indicate a gas forming organism causing an abscess (arrowhead).

Diabetic Foot Osteomyelitis

Image 2 (Plain Radiography): Extensive destructive changes consistent with a pyogenic infection which involves the IP joint of the great toe, all phalanges of the 2nd toe and 2nd MTP joint, all phalanges of the 3rd toe and 3rd MTP joint, proximal phalanx of the 4th toe and 4th MTP joint.

Diabetic Foot Osteomyelitis

Image 3 (Radionuclide Scan): Dual bone/white cell study (Tc-99 MBP/In-111 WBC). Delayed bone scan demonstrates intense focal uptake in the medial aspect of the proximal part of the distal phalanx of the right 1st toe. White cell study demonstrates intense focal uptake corresponding to the medial aspect of the proximal part of the distal phalanx of the right 1st toe. This scintigraphic appearance is consistent with osteomyelitis.
There is also focal intense uptake on bone scan in the inferior aspect of the calcaneo-cuboidal junction, which is not demonstrated on white cell study. This may represent neuroarthropathy or tendonitis.

Diabetic Foot Osteomyelitis

Image 4 (Bone Biopsy): Needle biopsy under fluoroscopic guidance of a bony erosion involving the proximal phalanx of the right great toe. Patient had a preceding dual bone/white cell study which showed a scintigraphic appearance consistent with partially treated osteomyelitis.

Diabetic Foot Osteomyelitis

  • Diabetic foot complications are the most common cause for non-traumatic lower limb amputation, with the presence of osteomyelitis increasing the risk of amputation
  • Physical examination and laboratory findings which have shown to be likelihood of osteomyelitis include bone on view or positive probe to bone; ulcer area >2cm2; ulcer depth >3mm; ESR >70mm/hr; ALP >135U/L or appearance of a "sausage" toe
  • Plain radiography of the foot is the initial imaging procedure for suspected osteomyelitis, but has poor sensitivity as osteomyelytic changes are delayed for 10-21 days following infection
  • Radionuclide scans have improved sensitivity and specificity over plain radiography
  • MRI is the most sensitive and specific imaging modality for diagnosing osteomyelitis, but it's use may be limited due to availability and high cost
  • Bone biopsy is the gold standard for diagnosing osteomyelitis. Culture of the causative pathogen(s) and their antibiotic sensitivities may be necessary to guide antibiotic therapy

Date of literature search: April 2013

The search methodology is available on request. Email

References are graded from Level I to V according to the Oxford Centre for Evidence-Based Medicine, Levels of Evidence. Download the document

  1. Butalia S, Palda VA, Sargeant RJ, Detsky AS, Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008;299(7):806-13. (Level II evidence)
  2. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA. 1991;266(9):1246-51. (Level II evidence)
  3. Wraight PR, Lawrence SM, Campbell DA, Colman PG. Creation of a multidisciplinary, evidence based, clinical guideline for the assessment, investigation and management of acute diabetes related foot complications. Diabet Med. 2005;22(2):127-36. (Evidence based guideline)
  4. Ertugrul MB, Baktiroglu S, Salman S, Unal S, Aksoy M, Berberoglu K, et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabet Med. 2006;23(6):649-53. (Level II evidence)
  5. Margolis D, Allen Taylor L, Hoffstad O, Berlin J. Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen. 2005;13(3):230-6. (Level II evidence)
  6. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5,Supplement):S1-66. (Review article)
  7. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39(7):885-910. (Review article)
  8. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995;273(9):721-3. (Level III evidence)
  9. Lavery L, Armstrong D, Peters EJG, Lipsky B. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care. 2007;30(2):270-4. (Level IV evidence)
  10. Shone A, Burnside J, Chipchase S, Game F, Jeffcoate W. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care. 2006;29(4):945. (Level III evidence)
  11. Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc. 2001;91(9):445-50. (Level IV evidence)
  12. Rajbhandari SM, Sutton M, Davies C, Tesfaye S, Ward JD. 'Sausage toe': a reliable sign of underlying osteomyelitis. Diabet Med. 2000;17(1):74-7. (Level III evidence)
  13. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35(4):280-3. (Level IV evidence)
  14. Oyen WJ, Netten PM, Lemmens JA, Claessens RA, Lutterman JA, van der Vliet JA, et al. Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G. J Nucl Med. 1992;33(7):1330-6. (Level IV evidence)
  15. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-73. (Evidence based guideline)
  16. Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008;47(4):519-27. (Level I evidence)
  17. Pineda C, Espinosa R, Pena A. Radiographic imaging in osteomyelitis: the role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging, and scintigraphy. Semin Plastic Surg. 2009;23(2):80-9. (Review article)
  18. Kapoor A, Page S, LaValley M, Gale D. R, Felson D. T. Magnetic resonance imaging for diagnosing foot osteomyelitis: A meta-analysis. Arch Intern Med. 2007;167(2):125-32. (Level II evidence)
  19. Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun. 2006;27(10):757-64. (Level II evidence)
  20. Termaat MF, Raijmakers PGHM, Scholten HJ, Bakker FC, Patka P, Haarman HJTM. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am. 2005;87(11):2464-71. (Level I/II evidence)
  21. Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Molecular Imaging and Biology : MIB. 2010;12(3):335-42. Available from: ProQuest Central; ProQuest Health & Medical Complete; ProQuest Nursing & Allied Health Source. (Level II evidence)
  22. White LM, Schweitzer ME, Deely DM, Gannon F. Study of osteomyelitis: utility of combined histologic and microbiologic evaluation of percutaneous biopsy samples. Radiology. 1995;197(3):840-2. (Level III evidence)
  23. Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubie M, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis. 2006;42(1):57-62. (Level II evidence)

Pathway User Guide

Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.

White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).

Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.

Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.

The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.

SYMBOL RRL EFFECTIVE DOSE RANGE
No radiation None 0
Minimal radiation Minimal < 1 millisieverts
Low radiation Low 1-5 mSv
Medium radiation Medium 5-10 mSv
High radiation High >10 mSv

Disclaimer

Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.

Report an Issue

Spotted an error or outdated info? Click to tell us.

Date reviewed: August 2013 Please note that this pathway is subject to review and revision. Plain radiography High clinical suspicion osteomyelits? Yes* Radiographic changes compatible with osteomyelitis? Consider bone biopsy Presumed osteomyelitis DIABETIC FOOT ULCER No Treat as osteomyelits No Yes No Yes Treat as osteomyelits Suggestive of osteomyelitis? MRI contraindicated or unavailable No Yes* Repeat radiograph in 2 weeks *Consider Charcot arthropathy as a differential or concomitant diagnosis if peripheral neuropathy is present This pathway focuses on the algorithm used to diagnose infection or osteomyelitis underlying a diabetic foot ulcer. Other important considerations when evaluating a diabetic foot is whether there is neuroarthropathy and/or peripheral vascular disease present. Bone on view or positive probe to bone? Consider bone biopsy Nuclear medicine scan MRI Consider bone biopsy Treat as osteomyelits Click here for Peripheral Arterial Disease (Suspected) pathway.

Diabetic Foot Ulcer

Diabetic Foot Ulcer

Diabetic foot complications are the most common cause for non-traumatic lower limb amputation, with the presence of osteomyelitis increasing the risk of amputation.

  • Diabetic foot complications are the most common cause for non-traumatic lower limb amputation
  • An estimated 15% of patients with diabetes will develop a foot ulcer during the course of their disease, with 85% of diabetes related lower limb amputations preceded by a foot ulcer
  • Foot disorders are the most common diabetic complication requiring hospitalisation, and are associated with the longest length of stay
  • Approximately 20% of diabetic inpatients will have foot related complications which require acute care and/or management ,
  • Osteomyelitis in the diabetic foot generally occurs by the direct extension of infection from underling soft tissue ulcers, with bacteria penetrating cortical bone to access the marrow cavity
  • Osteomyelitis is a diagnostic challenge, and imaging is commonly utilised
  • The presence of osteomyelitis increases the risk of amputation ,,

Clinical Findings

  • The signs and symptoms of infection may be absent or masked by the coexistence of vascular disease or neuropathy
  • Clinical evaluation should include an assessment of the patient's diabetes
  • The physical examination and laboratory findings which have shown to be likelihood of osteomyelitis include
    • Bone exposure – direct visualisation of bone or the ability to probe the base of the wound to bone. Depending on prevalence (sensitivity 38-87%; specificity 85-91%; positive likelihood ratio 6.4; negative LR 0.39)
    • Ulcer area larger then 2cm2 (sensitivity 56%; specificity 92%)
    • Deep (>3mm depth) ulcer (sensitivity 74%, specificity 77%)
    • ESR >70mm/h (sensitivity 90%; specificity 100%)
    • ALP >135U/L (specificity 100%)
    • "Sausage toe" appearance (i.e. red swollen digit) in instances of toe ulceration
  • Factors that did not modify the probability of osteomyelitis
    • Presence or absence of ulcer inflammation
    • Elevated white blood cell count, regardless of cut off applied
    • Result of swab culture

Plain Radiography

Initial procedure for imaging suspected osteomyelitis in the diabetic patient, but has poor sensitivity.

  • Initial procedure for imaging suspected osteomyelitis in the diabetic patient
  • Evidence of progression or resolution may be used to monitor response to antibiotic treatment
  • Characteristic signs of osteomyelitis on plain radiograph include cortical erosion, periosteal reaction, mixed lucency and sclerosis
  • Pooled sensitivity of 54% and specificity of 68% for osteomyelitis on recent meta-analysis
  • Sensitivity is limited as radiological changes are delayed for up to four weeks following infection. Typically radiographs don’t show abnormalities until about two weeks after initial infection, when nearly 50% of the bone mineral content has been lost ,
  • Specificity is limited by difficulty differentiating infection from neuro-osteoarthropathy in a patient with bony destruction (Charcot’s arthropathy)
  • Plain radiographs can also reveal presence of radio-opaque foreign bodies, gas in soft tissues, calcified arteries fractures or bony abnormalities ,
  • Normal plain radiographs do not exclude osteomyelitis. An abnormal plain radiographs doubles the odds of osteomyelitis based on a limited systematic review

Bone Biopsy

Bone biopsy

Gold standard for diagnosis of osteomyelitis.

  • The gold standard for diagnosis of osteomyelitis
  • Bone biopsy has a role not only in the diagnosis of osteomyelitis, but also the isolation of causative pathogen(s) and their antibiotic sensitivities to guide therapy
  • Bone biopsy is performed under sterile conditions either during surgical debridement or percutaneously though uninvolved skin under fluoroscopic or CT guidance
  • Ideally bone specimens should be sent for both histopathology and microbiology ,,
  • Diagnosis of osteomyelitis is based on isolation of bacteria and findings of osteonecrosis and infiltration of the bone with inflammatory cells on histopathology
  • Superficial swab culture does not reliably predict the bacteria causing osteomyelitis. Swab culture identified the identical pathogen as bone culture in only 22.5% of isolates
  • Disadvantages of bone biopsy include cost, availability of equipment and expertise, interference by antibiotics in culture results and potential for sampling error (false negative), contamination (false positive), invasiveness of the procedure and patient discomfort
  • Bone biopsy should be avoided in patients with advanced vascular disease as the incision for bone biopsy may not heal ,
  • There have been no published reports of complications associated with bone biopsy of the foot

Bone on view or positive probe to bone?

Bone exposure

A positive examination finding increases the likelihood of osteomyelitis by over six-fold.

Magnetic Resonance Imaging (MRI)

Magnetic resonance imaging

Most sensitive and specific imaging modality for diagnosing osteomyelitis.

  • Preferred advanced imaging modality for diagnosing osteomyelitis
  • Two metaanalyses reported similar pooled sensitivities of 90% (range 77-100%) and specificities of 79-82.5% (range 40-100%) in the diagnosis of foot osteomyelitis, outperforming plain radiography, 99mTc bone scanning and leucocyte scintigraphy ,
  • Advantages
    • No ionising radiation
    • Optimal visualisation of soft tissue structures, including detection of sinus tracts, deep tissue necrosis, abscesses and other inflammatory changes
    • High sensitivity in early stages - reveals bony oedema useful for early detection of infection

Nuclear Medicine Scans

Nuclear medicine study

Improved sensitivity (and also improved specificity with labelled leucocyte scintigraphy) over plain radiographs for detecting osteomyelitis during early stages of disease.

  • Nuclear imaging scans are more sensitive than radiographs for detecting osteomyelitis during early stages of the disease, however they have poor specificity and abnormalities are slow to resolve
  • Focal hyperperfusion, hyperaemia and bony uptake on delayed images are signs of osteomyelitis on bone scan. These signs may also be seen in other conditions such as fracture, neuroarthropathy and chronic soft tissue infection ,
  • Three phase technetium bone scan (Tc-99 MDP) has been reported on recent meta-analyses to be sensitive (80-90% but not specific (28-46%) for osteomyelitis, indicating poor discriminating ability. , The diagnostic performance was markedly inferior to MRI (diagnostic odds ratio 3.5 versus 150)
  • Labelled leucocyte scintigraphy with either indium-111 (111In) or technetium-99 (99mTc), improves specificity (to 74 and 85% respectively) for diagnosing acute infections
  • A combined dual study of Tc-99 MDP and labelled leucocyte scintigraphy (Indium-111) may improve sensitivity and specificity ,
  • Recent data suggest a role for FDG-PET/CT or SPECT/CT with bone and leukocyte scanning but the utility and cost effectiveness of this approach requires further study and is currently not recommended routinely by expert guidelines ,
  • Where MRI is unavailable or contraindicated, a radionuclide bone scan and a labelled white blood cell scan is recommended as the best alternative to rule out osteomyelitis15 A negative bone scan effectively excludes osteomyelitis

Peripheral Arterial Disease (Suspected)

Go to the pathway

Peripheral Arterial Disease (Suspected)

  • Acute Abdomen
  • Breast
  • Cancer Staging
  • Cardiovascular
  • Ear, Nose & Throat
  • Endocrine
  • Gastrointestinal
  • Kidney and Urinary Tract
  • Liver and Biliary
  • Musculoskeletal Non-Trauma
  • Neurological
  • Obstetric & Gynaecological
  • Paediatric
  • Pancreas
  • Respiratory
  • Trauma
    • Trauma - Musculoskeletal
    • Trauma - Head
    • Trauma - Visceral
    • Trauma - Paediatric
  • Musculoskeletal Non-Trauma

    • Musculoskeletal Non-Trauma
      • Bone Metastases (Suspected)
      • Bone pain
      • Foot ulcer (diabetic)
      • Hip Avascular Necrosis (Suspected)
      • Hip pain (non-traumatic)
      • Knee pain (non-traumatic)
      • Low Back Pain (Acute)
      • Multiple Myeloma (Suspected)
      • Neck pain (non-traumatic)
      • Orbital Foreign Body (Suspected)
      • Osteomyelitis (suspected acute)
      • Shoulder Pain (Chronic)
      • Soft tissue mass
      • Temporomandibular Joint Disorders (Suspected)

    Diagnostic Imaging Pathways

    The DIP pathways are a step-by-step guides to help clinicians choose the most appropriate imaging for each clinical scenario 

    “Trusted by clinicians worldwide since 2007, Diagnostic Imaging Pathways provides clear, evidence-based imaging guidelines. Our pathways support better decision-making and help improve healthcare outcomes—especially in emerging nations. 

    DIP functions and thrives wholeheartedly under the pillars of diversity, inclusivity and respect for all."

    • Pathways
    • Normal Anatomy
    • Medical Images
    • Radiation Module
    • Radiation Quiz
    • Information for Consumers
    • Governance
    • About Imaging
    • Production
    • Search
    • Login
    • Get in Touch
    © Diagnostic Imaging Pathways (DIP) 2025
    Code of Conduct    Terms and Conditions of Use
    General Site Navigation

    Information For Consumers

    • General Information About Diagnostic Imaging
      • Colorectal (Bowel) Cancer Screening
      • Colorectal (Bowel) Cancer Screening (Australia)
      • Consent to Procedure or Treatment
      • Radiation Risks of X-rays and Scans
    • Imaging Pathways
      • Ankle Injury (Suspected)
      • Bowel Cancer (Staging)
      • Deep Venous Thrombosis ( Leg, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Headache (Constant or Repeated)
      • Hip Fracture (Suspected)
      • Hypertension
      • Low Back Pain (Acute)
      • Lung Cancer (Staging)
      • Neck Pain (Non-Traumatic)
      • Renal Colic
      • Respiratory Illness (Acute)
      • Scaphoid Fracture (Suspected)
      • Shoulder (Pain or Instability)
      • Sinusitis (Acute)
      • Sinusitis (Chronic)
      • Stress Fracture (Suspected)
    • Imaging Procedures
      • Angiography (Angiogram)
      • Arthrogram
      • Bone Scan
      • Computed Tomography (CT)
      • Computed Tomography (CT) Angiography
      • Inferior Vena Cava (IVC) Filters
      • Intravenous Pyelogram (IVP)
      • Magnetic Resonance Angiography (MRA)
      • Magnetic Resonance Imaging (MRI)
      • Myelogram
      • Orthopantomogram (OPG)
      • Percutaneous Transthoracic Fine Needle Aspiration (FNA) or Biopsy
      • Positron Emission Tomography (PET)
      • Renal Artery Angioplasty and Stent
      • Renal Scan
      • Ultrasound
      • Ultrasound (Doppler)
      • Ultrasound (Endoscopic Rectal)
      • Venography (Venogram)
      • X-ray (Chest)
      • X-ray (Plain Radiograph)

    Governance

    • History
      • 1990s to 2012
      • 2012 to 2016
      • 2016 to 11 April 2022
      • From 12 April 2022
      • Introduction
      • List of acronyms used on this site
    • Organisation
      • 2003 - 2012
      • 2013 - 2016
      • 2017 - 11 April 2022
      • Post 12 April 2022
    • Personnel
      • Clinical Advisors
      • Contractors
      • Contributors
      • Editor
      • Editorial Panel - Post 2022
      • Editorial Panel - Pre 2022
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Project Officers
      • Quality Coordinator
      • Research Registrar
      • Responsibilites
      • Steering Committee
      • Steering Committee
    • Responsibilities, Achievements
      • Accreditation and Endorsement
      • Clinical Advisors
      • Editor
      • Editorial Panel
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Pathway Creation, Review and Revision
      • Quality Coordinator
      • Research Registrar
      • Steering Committee

    About Imaging

    • About Imaging
      • Bleeding Risk and Assessment
      • General Principles in Requesting and Providing Imaging Investigations
      • Imaging During Pregnancy and Lactation
      • Ionising Radiation in Diagnostic Imaging
      • Ionising Radiation in Paediatric Imaging
    • Common Procedures
      • Computed Tomography
      • Gastrointestinal Contrast Examinations
      • High Resolution Computed Tomography
      • Magnetic Resonance Imaging
      • Nuclear Medicine
      • Positron Emission Tomography
      • Ultrasound
    • Contrast Agents
      • Gadolinium Contrast for MRI scans
      • Iodinated Contrast for CT scans
      • Ultrasound Contrast Media

    Production

    • Editorial Independence
      • Disclosure of Conflict of Interest
      • Funding Policy & Sources
      • Management of Conflict of Interest
    • Processes for Creating and Managing Content
      • Creation of a New Pathway
      • Creation of New Information for Consumers
      • Review and Revision of a Pathway
      • Review and Revision of Information for Consumers
    • Production
      • Initial Engagement with Consumers
      • Principles for Creating and Managing Content